“…After the induction of diabetes, 210 SD rats were randomly assigned to the following groups: the sham group, which received the same operation except that the suture around the left anterior descending coronary artery was left untied; the MI/R + V group, which was orally treated with vehicle (distilled water, 0.5 mL/d) for 3 consecutive days and once again right before the MI/R operation; the MI/R + PD group, which was orally treated with polydatin (PD, Aladdin Chemicals, Shanghai, China; 20 mg/kg/d) for 3 consecutive days and once again right before the MI/R operation; the MI/R + PD + DAPT group, which was treated with polydatin (as above) and DAPT (Santa Cruz, CA, USA; 50 mg/kg, intraperitoneally, 20 min before the beginning of myocardial reperfusion); the MI/R + PD + LY group, which was treated with polydatin (as above) and LY294002 (LY, Santa Cruz, CA, USA; 30 mg/kg, intraperitoneally, 20 min before the beginning of myocardial reperfusion); the sham + DAPT group, which received sham operation and DAPT injection (as above); and the sham + LY group, which received sham operation and LY injection (as above). The dosages of polydatin and exogenous inhibitors were chosen based on previous publications [ 11 , 12 , 18 , 19 , 23 , 24 ]. MI/R surgery was carried out as described previously [ 23 ].…”